(Circulation. 2000;102:2720.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Increased Plasma P-Selectin and Decreased Thrombomodulin in Pulmonary Arterial Hypertension Were Improved by Continuous Prostacyclin Therapy
From the Division of Cardiology and Pulmonary Circulation, Department of Medicine, National Cardiovascular Center, Osaka, Japan.
Correspondence to Fumio Sakamaki, MD, Division of Cardiology and Pulmonary Circulation, Department of Medicine, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita-shi, Osaka 565-8565, Japan. E-mail fsakamak{at}hsp.ncvc.go.jp
Background—Thrombosis in situ related to endothelial cell injury may contribute to the development of pulmonary hypertension (PH). P-selectin, a leukocyte adhesion receptor present in endothelial cells and platelets, reflects endothelial injury and platelet activation, and thrombomodulin (TM), a receptor for thrombin and a major anticoagulant proteoglycan on the endothelial membrane, reflects the anticoagulant activity of the endothelium.
Methods and Results—To assess abnormal coagulation due to endothelial injury in patients with PH, plasma levels of soluble P-selectin and TM were measured in 32 patients with primary PH (PPH), 25 with secondary pulmonary arterial hypertension (sPAH), 31 with pulmonary venous hypertension (PVH), and 17 healthy subjects (Control). These measurements were repeated after continuous infusion of prostacyclin in 15 patients with PPH and 3 with sPAH. P-selectin levels in both the sPAH and PPH groups were significantly higher than those in the Control and PVH groups (P<0.05). Plasma TM level in the PPH group was significantly lower than those in the other groups (P<0.01). After prostacyclin therapy, the lower TM level was increased and the higher P-selectin level was decreased (P<0.05).
Conclusions—Decreased TM and increased P-selectin in PPH and sPAH may reflect in situ thrombosis due to endothelial injury. Prostacyclin may act not only as a vasodilator but also as an agent that improves endothelial injury and altered hemostasis in pulmonary arterial injury.
Key Words: prostaglandins • pulmonary heart disease • hypertension, pulmonary • endothelium • thrombosis
This article has been cited by other articles:
 |
|
 |
|
  M. Roth, M. Rupp, S. Hofmann, M. Mittal, B. Fuchs, N. Sommer, N. Parajuli, K. Quanz, D. Schubert, E. Dony, et al. Heme Oxygenase-2 and Large-Conductance Ca2+-activated K+ Channels: Lung Vascular Effects of Hypoxia Am. J. Respir. Crit. Care Med., August 15, 2009; 180(4): 353 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Hassoun, L. Mouthon, J. A. Barbera, S. Eddahibi, S. C. Flores, F. Grimminger, P. L. Jones, M. L. Maitland, E. D. Michelakis, N. W. Morrell, et al. Inflammation, growth factors, and pulmonary vascular remodeling. J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S10 - S19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Chin, R. N. Channick, J. A. de Lemos, N. H. Kim, F. Torres, and L. J. Rubin Hemodynamics and Epoprostenol Use Are Associated With Thrombocytopenia in Pulmonary Arterial Hypertension Chest, January 1, 2009; 135(1): 130 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Otterdal, A. K. Andreassen, A. Yndestad, E. Oie, W. J. Sandberg, C. P. Dahl, T. M. Pedersen, T. Ueland, L. Gullestad, F. R. Brosstad, et al. Raised LIGHT Levels in Pulmonary Arterial Hypertension: Potential Role in Thrombus Formation Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 202 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Robbins, S. M. Kawut, D. Yung, M. P. Reilly, W. Lloyd, G. Cunningham, J. Loscalzo, S. E. Kimmel, B. W. Christman, and R. J. Barst A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension. Eur. Respir. J., March 1, 2006; 27(3): 578 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hesselstrand, R. Ekman, J. Eskilsson, A. Isaksson, A. Scheja, A.-K. Ohlin, and A. Akesson Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992-2001 Rheumatology, March 1, 2005; 44(3): 366 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Rabausch, E. Bretschneider, M. Sarbia, J. Meyer-Kirchrath, P. Censarek, R. Pape, J. W. Fischer, K. Schror, and A.-A. Weber Regulation of Thrombomodulin Expression in Human Vascular Smooth Muscle Cells by COX-2-Derived Prostaglandins Circ. Res., January 7, 2005; 96(1): e1 - e6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Pidgeon, R. Tamosiuniene, G. Chen, I. Leonard, O. Belton, A. Bradford, and D. J. Fitzgerald Intravascular Thrombosis After Hypoxia-Induced Pulmonary Hypertension: Regulation by Cyclooxygenase-2 Circulation, October 26, 2004; 110(17): 2701 - 2707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Budhiraja, R. M. Tuder, and P. M. Hassoun Endothelial Dysfunction in Pulmonary Hypertension Circulation, January 20, 2004; 109(2): 159 - 165. [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Blann, S. K. Nadar, and G. Y.H. Lip The adhesion molecule P-selectin and cardiovascular disease Eur. Heart J., December 2, 2003; 24(24): 2166 - 2179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sakamaki, S. Kyotani, N. Nagaya, N. Sato, H. Oya, and N. Nakanishi Increase in Thrombomodulin Concentrations After Pulmonary Thromboendarterectomy in Chronic Thromboembolic Pulmonary Hypertension Chest, October 1, 2003; 124(4): 1305 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H. Kim, R. N. Channick, and L. J. Rubin Successful Withdrawal of Long-term Epoprostenol Therapy for Pulmonary Arterial Hypertension Chest, October 1, 2003; 124(4): 1612 - 1615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Sperry, C. B. Deming, C. Bian, P. L. Walinsky, D. A. Kass, F. D. Kolodgie, R. Virmani, A. Y. Kim, and J. J. Rade Wall Tension Is a Potent Negative Regulator of In Vivo Thrombomodulin Expression Circ. Res., January 10, 2003; 92(1): 41 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Lopes, L. H. Caramuru, and N. Y. Maeda Endothelial Dysfunction Associated with Chronic Intravascular Coagulation in Secondary Pulmonary Hypertension Clinical and Applied Thrombosis/Hemostasis, October 1, 2002; 8(4): 353 - 358. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Chatterjee, T. De Marco, and J. S. Alpert Pulmonary Hypertension: Hemodynamic Diagnosis and Management Arch Intern Med, September 23, 2002; 162(17): 1925 - 1933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Edelberg, P. D. Christie, and R. D. Rosenberg Regulation of Vascular Bed-Specific Prothrombotic Potential Circ. Res., July 20, 2001; 89(2): 117 - 124. [Abstract] [Full Text] [PDF]
|
|